Volgende

Automatisch afspelen

Long-term trial supports CD19-targeted CAR T cells for relapsed/refractory CLL

2 Bekeken • 07/14/23
Delen
insluiten
administrator
administrator
abonnees
0

In this episode, Mark Geyer and colleagues demonstrate that second-generation CD19-targeted CAR T cell therapy following conditioning chemotherapy is tolerated in patients with relapsed/refractory CLL and can result in complete remission in a subset of patients…

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen